|
|
Via Belluno, 1
Roma, 00161 Italy
phone:(39) 064 424 5034
fax:(39) 064 424 4958
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.italfarmaco.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| New indications and delivery systems for existing drugs for cardiovascular and immunologic diseases. |
|
| Management |
| F. Autuori, Chief Executive Officer; C. Bianchini, Chief Science Officer; P. Mascagni, Head of Research |
| |
|
|
| |
|
| Keywords |
| drugs, pharmaceuticals, delivery, cardiovascular, immunology, inflammation, cytokines, oral, AllergyImmunology |
|
|
|
| Description |
|
Italfarmaco Group develops new indications and new delivery systems for drugs already on the market and in the fields of cardiology and immunology. |
|
| Products / Services |
Italfarmaco's primary cardiovascular product is oligopeptides effective against deteriorations of the coronary microcirculation induced by ischaemia and reperfusion. In this area of immunology, the company is developing selective inhibitors of pro-inflammatory cytokine which are active by the oral route for the treatment of acute and chronic inflammatory diseases.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members